Reducing the risk of drug-drug interaction: A goal of rational drug development

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 1, 1996, Pages 3-6

  Preshorn, S H ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; SERTRALINE;

DRUG INTERACTION; DRUG RESEARCH; HUMAN; NOTE; PREVENTION; PRIORITY JOURNAL;

1-NAPHTHYLAMINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; HUMANS; MIXED FUNCTION OXYGENASES; OXIDOREDUCTASES; PSYCHOTROPIC DRUGS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 0029916473     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)